Table 1.
Background characteristics of sample (n = 42)
| Total | (%) | |
|---|---|---|
| Age | ||
| 50–59 | 30 | (71) |
| 60–69 | 12 | (29) |
| Gender | ||
| Man | 24 | (57) |
| Woman | 17 | (41) |
| Other | 1 | (2) |
| Race/ethnicity a | ||
| Asian | 2 | (5) |
| Black | 1 | (2) |
| Indigenous | 16 | (40) |
| White | 26 | (62) |
| Drug use in past 30 days a | ||
| Amphetamine | 24 | (57) |
| Cocaine | 34 | (81) |
| Crystal methamphetamine | 17 | (41) |
| Opioids (heroin/fentanyl) | 19 | (45) |
| Non‐medical prescription opioid use | 14 | (33) |
| Ritalin | 12 | (31) |
| Other | 16 | (40) |
| Comorbidities a | ||
| Chronic pain | 27 | (64) |
| Chronic obstructive pulmonary disease (COPD) | 12 | (31) |
| Cardiovascular disease | 10 | (24) |
| Diabetes | 2 | (5) |
| Hepatitis C | 28 | (67) |
| Mental illness | 17 | (41) |
| Opioid use disorder | 11 | (26) |
| Stimulant use disorder | 10 | (24) |
| Other | 21 | (50) |
aParticipants could report multiple categories.